Status:
UNKNOWN
The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Antiphospholipid Syndrome
Endothelial Dysfunction
Eligibility:
All Genders
20+ years
Brief Summary
Patients with hyperuricemia were confirmed to have higher risks of cardiovascular disease, but the exact mechanism remained to be elucidated. Many connective tissue diseases such as rheumatoid arthrit...
Detailed Description
Patients with hyperuricemia were confirmed to have higher risks of cardiovascular disease, but the exact mechanism remained to be elucidated. Many connective tissue diseases such as rheumatoid arthrit...
Eligibility Criteria
Inclusion
- Patient with gouty arthritis
- Patient with asymptomatic hyperurecemia
- Patient of osteoarthritis but without hyperuricemia and gout
Exclusion
- Patient younger than 20 y/o.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01818505
Start Date
March 1 2013
Last Update
April 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Yun-Lin Branch
Dou-Liou City, Yun-Lin County, Taiwan, 640